Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases

References

• Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol 2006;24:4–8.
   PubMed Web of Science ®Google Scholar
• Slavkin HC, Bartold PM. Challenges and potential in tissue engineering. Periodontol 2000 2006; 41:9–15.
   Google Scholar
• Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004;428:487–492.
   PubMed Web of Science ®Google Scholar
• Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584–589.
   PubMed Web of Science ®Google Scholar
• Mathers WD. Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO J 2000;26:159–165.
   PubMedGoogle Scholar
• Pflugfelder SC, Wilhelmus KR, Osato MS, Matoba AY, Font RL. The autoimmune nature of aqueous tear deficiency. Ophthalmology 1986;93:1513–1517.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Solomon A, Dursun D, Li DQ. Dry eye and delayed tear clearance: “a call to arms”. Adv Exp Med Biol 2002;506:739–743.
   PubMed Web of Science ®Google Scholar
• Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res 2003;76:521–542.
   PubMed Web of Science ®Google Scholar
• Nasu M, Matsubara O, Yamamoto H. Post-mortem prevalence of lymphocytic infiltration of the lacrymal gland: a comparative study in autoimmune and non-autoimmune diseases. J Pathol 1984;143:11–15.
   PubMed Web of Science ®Google Scholar
• Inatomi T, Nakamura T, Koizumi N, Sotozono C, Kinoshita S. Current concepts and challenges in ocular surface reconstruction using cultivated mucosal epithelial transplantation. Cornea 2005;24:S32–S38.
   PubMed Web of Science ®Google Scholar
• Inatomi T, Nakamura T, Kojyo M, Koizumi N, Sotozono C, Kinoshita S. Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty. Am J Ophthalmol 2006;142:757–764.
   PubMed Web of Science ®Google Scholar
• James SE, Rowe A, Ilari L, Daya S, Martin R. The potential for eye bank limbal rings to generate cultured corneal epithelial allografts. Cornea 2001;20:488–494.
   PubMed Web of Science ®Google Scholar
• Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol 2007;125:1337–1344.
   PubMedGoogle Scholar
• Kinoshita S, Koizumi N, Nakamura T. Transplantable cultivated mucosal epithelial sheet for ocular surface reconstruction. Exp Eye Res 2004;78:483–491.
   PubMed Web of Science ®Google Scholar
• Satake Y, Dogru M, Yamane GY, Kinoshita S, Tsubota K, Shimazaki J. Barrier function and cytologic features of the ocular surface epithelium after autologous cultivated oral mucosal epithelial transplantation. Arch Ophthalmol 2008;126:23–28.
   PubMed Web of Science ®Google Scholar
• Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res 2008;57:253–258.
   PubMed Web of Science ®Google Scholar
• Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000;107: 1347–1351; discussion 1351–1342.
   PubMed Web of Science ®Google Scholar
• Marquez EB, De Ortueta D, Royo SB, Martinez-Carpio PA. Epidermal growth factor receptor in corneal damage: update and new insights from recent reports. Cutan Ocul Toxicol 2011;30:7–14.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28:4551–4560.
   PubMed Web of Science ®Google Scholar
• Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 2004;79:677–688.
   PubMed Web of Science ®Google Scholar
• Orive G, Gascon AR, Hernandez RM, Dominguez-Gil A, Pedraz JL. Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol Sci 2004;25:382–387.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernandez RM, Rodriguez Gascon A, Dominguez-Gil A, Pedraz JL. Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 2003;14:659–664.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 2010;62:741–752.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008;29:37–41.
   PubMed Web of Science ®Google Scholar
• Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol 1999;83:390–395.
   PubMed Web of Science ®Google Scholar
• Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467–1474.
   PubMed Web of Science ®Google Scholar
• Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007;25:230–240.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci 2008;13:3532–3548.
   PubMed Web of Science ®Google Scholar
• Lopez-Plandolit S, Morales MC, Freire V, Etxebarria J, Duran JA. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 2010;29:843–848.
   PubMed Web of Science ®Google Scholar
• Lopez-Plandolit S, Morales MC, Freire V, Grau AE, Duran JA. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea 2011;30:1312–1317.
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009;23:177–189.
   PubMed Web of Science ®Google Scholar
• Childs CB, Proper JA, Tucker RF, Moses HL. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci U S A 1982;79:5312–5316.
   PubMed Web of Science ®Google Scholar
• Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion (Paris) 1990;30:741–747.
   PubMed Web of Science ®Google Scholar
• Leitner GC, Gruber R, Neumuller J, Wagner A, Kloimstein P, Hocker P, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang 2006;91:135–139.
   PubMed Web of Science ®Google Scholar
• Tsay RC, Vo J, Burke A, Eisig SB, Lu HH, Landesberg R. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg 2005;63:521–528.
   PubMed Web of Science ®Google Scholar
• Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004;34:665–671.
   PubMed Web of Science ®Google Scholar
• Fernandez-Barbero JE, Galindo-Moreno P, Avila-Ortiz G, Caba O, Sanchez-Fernandez E, Wang HL. Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin Oral Implants Res 2006;17:687–693.
   PubMed Web of Science ®Google Scholar
• Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529–535.
   PubMed Web of Science ®Google Scholar
• Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol 1994;78:401–408.
   PubMed Web of Science ®Google Scholar
• Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 2005;24:S2–S11.
   PubMed Web of Science ®Google Scholar
• Wilson SE, Netto M, Ambrosio R, Jr. Corneal cells: chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol 2003;136:530–536.
   PubMed Web of Science ®Google Scholar
• Dupps WJ, Jr., Wilson SE. Biomechanics and wound healing in the cornea. Exp Eye Res 2006;83:709–720.
   PubMed Web of Science ®Google Scholar
• Fu Y, Liu J, Tseng SC. Ocular surface deficits contributing to persistent epithelial defect after penetrating keratoplasty. Cornea 2012;31:723–729.
   PubMed Web of Science ®Google Scholar
• Anitua E, Muruzabal F, Alcalde I, Merayo-Lloves J, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res 2013;115:153–161.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Merayo-Lloves J, De la Fuente M, Muruzabal F, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci 2011;52:6066–6073.
   PubMed Web of Science ®Google Scholar
• Freire V, Andollo N, Etxebarria J, Duran JA, Morales MC. In vitro effects of three blood derivatives on human corneal epithelial cells. Invest Ophthalmol Vis Sci 2012;53:5571–5578.
   PubMed Web of Science ®Google Scholar
• Freire V, Andollo N, Etxebarria J, Hernaez-Moya R, Duran JA, Morales MC. Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study. Cornea 2014;33:614–620.
   PubMed Web of Science ®Google Scholar
• Garana RM, Petroll WM, Chen WT, Herman IM, Barry P, Andrews P, et al. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci 1992;33:3271–3282.
   PubMed Web of Science ®Google Scholar
• Jester JV, Petroll WM, Feng W, Essepian J, Cavanagh HD. Radial keratotomy. 1. The wound healing process and measurement of incisional gape in two animal models using in vivo confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:3255–3270.
   Google Scholar
• Maltseva O, Folger P, Zekaria D, Petridou S, Masur SK. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci 2001;42:2490–2495.
   PubMed Web of Science ®Google Scholar
• Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res 2006;82:788–797.
   PubMed Web of Science ®Google Scholar
• Mohan RR, Stapleton WM, Sinha S, Netto MV, Wilson SE. A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Exp Eye Res 2008;86:235–240.
   PubMed Web of Science ®Google Scholar
• Sakimoto T, Rosenblatt MI, Azar DT. Laser eye surgery for refractive errors. Lancet 2006;367:1432–1447.
   PubMed Web of Science ®Google Scholar
• Mietz H, Arnold G, Kirchhof B, Diestelhorst M, Krieglstein GK. Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 1996;234:364–368.
   PubMed Web of Science ®Google Scholar
• Skuta GL, Parrish RK, 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987;32:149–170.
   PubMed Web of Science ®Google Scholar
• Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 2012;157:29–38.
   PubMed Web of Science ®Google Scholar
• The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:93–107.
   Google Scholar
• Geerling G, Daniels JT, Dart JK, Cree IA, Khaw PT. Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 2001;42:948–956.
   PubMed Web of Science ®Google Scholar
• Tripathi BJ, Tripathi RC. Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro. Lens Eye Toxic Res 1989;6:395–403.
   PubMedGoogle Scholar
• Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther 2001;18:205–215.
   PubMed Web of Science ®Google Scholar
• Rocha GA, Acera A, Duran JA. Laser in situ keratomileusis flap necrosis after trigeminal nerve palsy. Arch Ophthalmol 2007;125:1423–1425.
   PubMedGoogle Scholar
• Alio JL, Pastor S, Ruiz-Colecha J, Rodriguez A, Artola A. Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma. J Refract Surg 2007;23:617–619.
   PubMed Web of Science ®Google Scholar
• Sharma A, Hindman HB. Aging: a predisposition to dry eyes. J Ophthalmol 2014;2014: 781683.
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264–1268.
   PubMed Web of Science ®Google Scholar
• Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 2014;157:799–806.
   PubMed Web of Science ®Google Scholar
• Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 2015;13:213–225.
   PubMed Web of Science ®Google Scholar
• Zhou XQ, Wei RL. Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis. Cornea 2014;33:760–767.
   PubMed Web of Science ®Google Scholar
• Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res 2007;39:124–129.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984–1989.
   PubMed Web of Science ®Google Scholar
• Lopez-Garcia JS, Garcia-Lozano I, Rivas L, Martinez-Garchitorena J. [Use of autologous serum in ophthalmic practice]. Arch Soc Esp Oftalmol 2007;82:9–20.
   PubMedGoogle Scholar
• Vajpayee RB, Mukerji N, Tandon R, Sharma N, Pandey RM, Biswas NR, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 2003;87:1312–1316.
   PubMed Web of Science ®Google Scholar
• Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology 2007;114:1286–1293 e1281.
   PubMed Web of Science ®Google Scholar
• Lopez-Plandolit S, Morales MC, Freire V, Etxebarria J, Duran JA. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 2010; 29:843–848.
   Google Scholar
• Marquez De Aracena Del Cid R, Montero De Espinosa Escoriaza I. Subconjunctival application of regenerative factor-rich plasma for the treatment of ocular alkali burns. Eur J Ophthalmol 2009;19:909–915.
   Google Scholar
• Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489–496.
   PubMed Web of Science ®Google Scholar
• Odrljin TM, Shainoff JR, Lawrence SO, Simpson-Haidaris PJ. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. Blood 1996;88:2050–2061.
   PubMed Web of Science ®Google Scholar
• Tamaki T, Aoki N. Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta 1981;661:280–286.
   PubMed Web of Science ®Google Scholar
• Alio JL, Rodriguez AE, Martinez LM, Rio AL. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. JAMA Ophthalmol 2013;131:745–751.
   PubMed Web of Science ®Google Scholar
• Alio JL, Rodriguez AE, Martinez LM. Bovine pericardium membrane (tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers. Cornea 2013;32:619–624.
   PubMed Web of Science ®Google Scholar